Jiajun Zhu
Molecular Biology · 2019–2022
A researcher in the Science corpus: 3 papers; trusts 5 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 123 citations into it
- Cancer Research — 85 citations into it
Whom Jiajun Zhu trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- B. Manning
- Lewis C. Cantley
- Craig B. Thompson
- Joshua D. Rabinowitz
- N. Pavlova
- R. A. Saxton
- M. V. Vander Heiden
Papers from Jiajun Zhu's perspective
Ordered by how strongly the researchers Jiajun Zhu trusts endorse each paper. Same corpus, a different order for every researcher.
- Activation of a metabolic gene regulatory network downstream of mTOR complex 1. (Molecules and Cells)
- Regulation of Ferroptotic Cancer Cell Death by GPX4 (Cell)
- Glutaminolysis and Transferrin Regulate Ferroptosis (Molecules and Cells)
- Activation of the p62-Keap1-NRF2 Pathway Protects against Ferroptosis in Hepatocellular Carcinoma Cells (Hepatology)
- SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. (Journal of Clinical Investigation)
- Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy. (Molecules and Cells)
- Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways (Cell Metabolism)
- FSP1 is a glutathione-independent ferroptosis suppressor (Nature)
- mTOR Signaling in Growth, Metabolism, and Disease (Cell)
- Exogenous Monounsaturated Fatty Acids Promote a Ferroptosis-Resistant Cell State (Cell Chemical Biology)
Their papers
- THE HALLMARKS OF CANCER METABOLISM: STILL EMERGING (2022) — 1,148 citations
- Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis (2020) — 837 citations
- Metabolic regulation of cell growth and proliferation (2019) — 941 citations